Ge‐Bo Wen

1.5k total citations
72 papers, 1.3k citations indexed

About

Ge‐Bo Wen is a scholar working on Molecular Biology, Cell Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Ge‐Bo Wen has authored 72 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 41 papers in Cell Biology and 7 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Ge‐Bo Wen's work include Hemoglobin structure and function (38 papers), Heme Oxygenase-1 and Carbon Monoxide (15 papers) and Porphyrin Metabolism and Disorders (12 papers). Ge‐Bo Wen is often cited by papers focused on Hemoglobin structure and function (38 papers), Heme Oxygenase-1 and Carbon Monoxide (15 papers) and Porphyrin Metabolism and Disorders (12 papers). Ge‐Bo Wen collaborates with scholars based in China, United States and Canada. Ge‐Bo Wen's co-authors include Ying‐Wu Lin, Shu‐Qin Gao, Xiangshi Tan, Jing Zhong, Xuyu Zu, Bo He, Renxian Cao, Ke‐Jie Du, Jianghua Liu and Jiakun Xu and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Biochemistry.

In The Last Decade

Ge‐Bo Wen

72 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ge‐Bo Wen China 20 807 354 198 143 117 72 1.3k
Alex D. Sheftel Canada 24 1.3k 1.7× 188 0.5× 170 0.9× 111 0.8× 233 2.0× 36 2.6k
Maria Luisa Di Paolo Italy 17 993 1.2× 89 0.3× 305 1.5× 132 0.9× 71 0.6× 70 1.7k
Or Kakhlon Israel 21 724 0.9× 146 0.4× 138 0.7× 115 0.8× 288 2.5× 41 1.9k
Michelle L. Turski United States 11 645 0.8× 113 0.3× 139 0.7× 399 2.8× 89 0.8× 20 1.6k
Silvina Epsztejn Israel 9 522 0.6× 62 0.2× 58 0.3× 120 0.8× 160 1.4× 9 1.6k
Ziyang Zhang China 25 933 1.2× 77 0.2× 113 0.6× 304 2.1× 62 0.5× 73 2.0k
Fulong Li China 22 899 1.1× 282 0.8× 183 0.9× 124 0.9× 67 0.6× 74 1.6k
Nadine Pollak Germany 10 588 0.7× 49 0.1× 98 0.5× 112 0.8× 72 0.6× 16 1.0k
Stephen W. Tuttle United States 19 839 1.0× 136 0.4× 294 1.5× 162 1.1× 88 0.8× 32 1.3k
Megan Whitnall Australia 8 754 0.9× 141 0.4× 74 0.4× 229 1.6× 90 0.8× 8 1.4k

Countries citing papers authored by Ge‐Bo Wen

Since Specialization
Citations

This map shows the geographic impact of Ge‐Bo Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ge‐Bo Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ge‐Bo Wen more than expected).

Fields of papers citing papers by Ge‐Bo Wen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ge‐Bo Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ge‐Bo Wen. The network helps show where Ge‐Bo Wen may publish in the future.

Co-authorship network of co-authors of Ge‐Bo Wen

This figure shows the co-authorship network connecting the top 25 collaborators of Ge‐Bo Wen. A scholar is included among the top collaborators of Ge‐Bo Wen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ge‐Bo Wen. Ge‐Bo Wen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Jiakun, et al.. (2021). Biotransformation of Lignin by an Artificial Heme Enzyme Designed in Myoglobin With a Covalently Linked Heme Group. Frontiers in Bioengineering and Biotechnology. 9. 664388–664388. 11 indexed citations
2.
Yang, Lu, Xinzhi Yang, Yong You, et al.. (2020). Sorting nexins: A novel promising therapy target for cancerous/neoplastic diseases. Journal of Cellular Physiology. 236(5). 3317–3335. 9 indexed citations
3.
Luo, Jie, Ke‐Jie Du, Hong Yuan, et al.. (2020). Rational Design of an Artificial Nuclease by Engineering a Hetero-Dinuclear Center of Mg-Heme in Myoglobin. ACS Catalysis. 10(24). 14359–14365. 17 indexed citations
4.
Wu, Li, Yun-Cheng Lv, Ying Lv, et al.. (2020). A novel secretagogin/ATF4 pathway is involved in oxidized LDL-induced endoplasmic reticulum stress and islet β-cell apoptosis. Acta Biochimica et Biophysica Sinica. 53(1). 54–62. 6 indexed citations
5.
Zhou, Shouhong, et al.. (2020). PRMT2 inhibits the formation of foam cell induced by ox-LDL in RAW 264.7 macrophage involving ABCA1 mediated cholesterol efflux. Biochemical and Biophysical Research Communications. 524(1). 77–82. 11 indexed citations
6.
Chen, Yajun, Yao Yao, Jing Wang, et al.. (2019). PRMT2β suppresses autophagy and glycolysis pathway in human breast cancer MCF-7 cell lines. Acta Biochimica et Biophysica Sinica. 51(3). 335–337. 6 indexed citations
7.
Zhang, Qinghai, Ling Chen, Zhibo Zhao, et al.. (2018). HMGA1 Mediated High-Glucose-Induced Vascular Smooth Muscle Cell Proliferation in Diabetes Mellitus: Association Between PI3K/Akt Signaling and HMGA1 Expression. DNA and Cell Biology. 37(4). 389–397. 10 indexed citations
8.
Zhong, Jing, Yajun Chen, Ling Chen, et al.. (2017). PRMT2β, a C-terminal splice variant of PRMT2, inhibits the growth of breast cancer cells. Oncology Reports. 38(2). 1303–1311. 12 indexed citations
9.
Liao, Fei, Hong Yuan, Ke‐Jie Du, et al.. (2016). Distinct roles of a tyrosine-associated hydrogen-bond network in fine-tuning the structure and function of heme proteins: two cases designed for myoglobin. Molecular BioSystems. 12(10). 3139–3145. 6 indexed citations
10.
Yuan, Hong, Hu Zhou, Shu‐Qin Gao, et al.. (2016). An intramolecular disulfide bond designed in myoglobin fine-tunes both protein structure and peroxidase activity. Archives of Biochemistry and Biophysics. 600. 47–55. 25 indexed citations
11.
Zhong, Jing, Chang Liu, Yajun Chen, et al.. (2016). The association between S100A13 and HMGA1 in the modulation of thyroid cancer proliferation and invasion. Journal of Translational Medicine. 14(1). 80–80. 30 indexed citations
12.
Zhang, Jing, Yan Cai, Ye‐Bo Zhou, et al.. (2014). C-type natriuretic peptide inhibiting vascular calcification might involve decreasing bone morphogenic protein 2 and osteopontin levels. Molecular and Cellular Biochemistry. 392(1-2). 65–76. 14 indexed citations
13.
You, Yong, Fang Liu, Ke‐Jie Du, Ge‐Bo Wen, & Ying‐Wu Lin. (2014). Structural and functional alterations of myoglobin by glucose-protein interactions. Journal of Molecular Modeling. 20(7). 2358–2358. 16 indexed citations
14.
Lin, Ying‐Wu, et al.. (2014). Computational insight into nitration of human myoglobin. Computational Biology and Chemistry. 52. 60–65. 10 indexed citations
15.
Yin, Kai, Zhongcheng Mo, Guojun Zhao, et al.. (2011). Tristetraprolin-dependent Post-transcriptional Regulation of Inflammatory Cytokine mRNA Expression by Apolipoprotein A-I. Journal of Biological Chemistry. 286(16). 13834–13845. 48 indexed citations
16.
Zhong, Jing, Renxian Cao, Jing Yang, et al.. (2011). Identification and expression analysis of a novel transcript of the human PRMT2 gene resulted from alternative polyadenylation in breast cancer. Gene. 487(1). 1–9. 28 indexed citations
17.
Ling, Hongyan, Ge‐Bo Wen, Shuidong Feng, et al.. (2011). MicroRNA‐375 promotes 3T3‐L1 adipocyte differentiation through modulation of extracellular signal‐regulated kinase signalling. Clinical and Experimental Pharmacology and Physiology. 38(4). 239–246. 115 indexed citations
18.
Liu, Jianghua, Kang Xu, Ge‐Bo Wen, et al.. (2008). Comparison of the effects of genistein and zoledronic acid on the bone loss in OPG-deficient mice. Bone. 42(5). 950–959. 16 indexed citations
20.
Jiang, Zhi‐Sheng, Ge‐Bo Wen, Robert R. Fandrich, et al.. (2006). High- but not low-molecular weight FGF-2 causes cardiac hypertrophy in vivo; possible involvement of cardiotrophin-1. Journal of Molecular and Cellular Cardiology. 42(1). 222–233. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026